See also this year's filing and all EDGAR filings for this company.
PDF Report 0001740547_2021_Urovant_Sciences_Ltd.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001740547')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001740547, Urovant Sciences Ltd.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 58,318,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,210,000 |
| 3 | remainder_Assets | 3,767,000 |
| 4 | LiabilitiesCurrent | 30,931,000 |
| 5 | LiabilitiesNoncurrent | 3,086,000 |
| 6 | remainder_Liabilities | 87,284,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 46,299,000 |
| 9 | ResearchAndDevelopmentExpense | 92,437,000 |
| 10 | remainder_Expenses | 65,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,944,000 |
| 13 | remainder_ComprehensiveNetIncome | 183,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,295,000 |
| 1 | Liabilities | 121,301,000 |
| 2 | Expenses | 138,801,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -58,006,000 |
| 5 | NetIncome | -146,745,000 |
| 6 | ComprehensiveNetIncome | -146,653,500 |
| 7 | BaseVar | 165,762,000 |
| 8 | EconomicCapitalRatio | -2.67 |
Edgar->Model Mapping
Feature Distribution
Change over Time
